NasdaqGM:TMDXMedical Equipment
TransMedics Group (TMDX) Stock Faces Margin Pressure After Record Revenue
TransMedics Group stock dropped about 5% to close near US$76 after the Q2 print, even though the business reported another quarter of record transplant revenue and stronger earnings. Coming into today, shares were modestly higher over the past month, so this pullback is affecting investors who had been leaning into the story.
The headline is simple: TransMedics delivered roughly US$190m of revenue with adjusted earnings per share around US$0.42, while telling investors it plans to spend more...